{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:42:52Z","timestamp":1771000972571,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.bpg.2011.10.010","type":"journal-article","created":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T00:31:11Z","timestamp":1322958671000},"page":"569-579","source":"Crossref","is-referenced-by-count":13,"title":["Chemoprevention in Barrett\u2019s oesophagus"],"prefix":"10.1016","volume":"25","author":[{"given":"Victoria","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2011.10.010_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1052-3359(25)00513-7","article-title":"Incidence, epidemiology and etiology of esophageal cancer","volume":"10","author":"Gamliel","year":"2000","journal-title":"Chest Surg Clin North Am"},{"key":"10.1016\/j.bpg.2011.10.010_bib2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","article-title":"Prevalence of Barrett\u2019s esophagus in the general population: an endoscopic study","volume":"129","author":"Ronkainen","year":"2005","journal-title":"Gastroenterology"},{"issue":"9666","key":"10.1016\/j.bpg.2011.10.010_bib3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(09)60487-6","article-title":"Barrett\u2019s oesophagus","volume":"373","author":"Shaheen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.10.010_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0016-5085(87)90847-X","article-title":"Barrett\u2019s esophagus. A prevalent, occult complication of gastroesophageal reflux disease","volume":"92","author":"Winters","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMcp012118","article-title":"Clinical practice. Barrett\u2019s Esophagus","volume":"346","author":"Spechler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2011.10.010_bib6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/gut.2004.063685","article-title":"Increasing incidence of Barrett\u2019s oesophagus in the general population","volume":"54","author":"Van Soest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.010_bib7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ijc.10721","article-title":"Continuing rising trend in oesophageal adenocarcinoma","volume":"102","author":"Powell","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpg.2011.10.010_bib8","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1053\/j.gastro.2005.10.037","article-title":"Is the incidence of esophageal adenocarcinomas in patients with Barrett\u2019s esophagus really overestimated?","volume":"129","author":"Younes","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib9","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","article-title":"Esophageal cancer","volume":"349","author":"Powell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2011.10.010_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/gast.2000.9302","article-title":"Is there publication bias in the reporting of cancer risk in Barrett\u2019s esophagus?","volume":"119","author":"Shaheen","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/gast.2002.31599","article-title":"Esophageal adenocarcinoma arising from Barrett\u2019s metaplasia has regional variations in the west","volume":"122","author":"Jankowski","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib12","doi-asserted-by":"crossref","unstructured":"de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett\u2019s oesophagus: a Dutch nationwide cohort study. Gut;59:1030\u20131036.","DOI":"10.1136\/gut.2009.176701"},{"key":"10.1016\/j.bpg.2011.10.010_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrc2773","article-title":"Barrett\u2019s oesophagus and oesophageal adenocarcinoma: time for a new synthesis","volume":"10","author":"Reid","year":"2010","journal-title":"Nat Rev"},{"key":"10.1016\/j.bpg.2011.10.010_bib14","series-title":"Information Centre, Lifestyles Statistics. Statistics on obesity, physical activity and diet: England","author":"The NHS","year":"2010"},{"issue":"872\u2013878","key":"10.1016\/j.bpg.2011.10.010_bib15","first-page":"59","article-title":"Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis","volume":"15","author":"Kubo","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.bpg.2011.10.010_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","article-title":"Metaanalysis: obesity and the risk for gastroesophageal reflux disease and its complications","volume":"143","author":"Hampel","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2011.10.010_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/gut.2007.131375","article-title":"Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus","volume":"57","author":"Whiteman","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.010_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2007.05.026","article-title":"Central adiposity and risk of Barrett\u2019s esophagus","volume":"133","author":"Edelstein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2007.04.046","article-title":"Abdominal obesity and body mass index as risk factors for Barrett\u2019s esophagus","volume":"133","author":"Corley","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.gastro.2004.08.014","article-title":"The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis","volume":"128","author":"Barlow","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.beem.2008.08.009","article-title":"Reducing the weight of cancer: mechanistic targets for breaking the obesitycarcinogenesis link","volume":"22","author":"Hursting","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bpg.2011.10.010_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0002-9440(10)65346-1","article-title":"Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus","volume":"154","author":"Jankowski","year":"1999","journal-title":"Am J Pathol"},{"issue":"Suppl I","key":"10.1016\/j.bpg.2011.10.010_bib23","first-page":"i6","article-title":"J-F Fle\u00b4jou Barrett\u2019s oesophagus: from metaplasia to dysplasia and cancer","volume":"54","year":"2005","journal-title":"Gut"},{"issue":"5 Suppl","key":"10.1016\/j.bpg.2011.10.010_bib24","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00004836-200305001-00002","article-title":"The natural history of dysplasia and cancer in esophagitis and Barrett esophagus","volume":"36","author":"Spechler","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.010_bib25","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1172\/JCI119018","article-title":"Dynamic effects of acid on Barrett\u2019s esophagus","volume":"98","author":"Fitzgerald","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2011.10.010_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/gast.1999.0029900327","article-title":"Differentiation and proliferation in Barrett\u2019s esophagus and the effects of acid suppression","volume":"117","author":"Ouatu-Lascar","year":"1999","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bpg.2011.10.010_bib27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1365-2036.2007.03325.x","article-title":"Systematic review: the Application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma","volume":"25","author":"Peters","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.10.010_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/dote\/10.1.29","article-title":"Reflux esophagitis in humans is a free radical event","volume":"10","author":"Wetscher","year":"1997","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.bpg.2011.10.010_bib29","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/471S10a","article-title":"The big C - for Chemoprevention","volume":"471","author":"Sporn","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2011.10.010_bib30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gut.49.6.761","article-title":"members of the Groupe d\u2019Etude de l\u2019Oesophage de Barrett ; Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology","volume":"49","author":"Couvelard","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.010_bib31","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1365-2036.2009.03969.x","article-title":"The Influence of symptom type and duration on the fate of the metaplastic columnar-lined oesophagus","volume":"29","author":"Gatenby","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.10.010_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2036.1995.tb00405.x","article-title":"Long term continuous omeprazole treatment of patients with Barrett\u2019s oesophagus","volume":"9","author":"Neumann","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.10.010_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2036.2001.00939.x","article-title":"Review article: Barrett\u2019s oesophagus, dysplasia and pharmacologic acid suppression","volume":"15","author":"Fitzgerald","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.10.010_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2036.2006.02825.x","article-title":"Continuous treatment of Barrett\u2019s oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence","volume":"23","author":"Cooper","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.10.010_bib35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2036.1993.tb00143.x","article-title":"Regression of columnar lined (Barrett\u2019s) oesophagus with continuous omeprazole therapy","volume":"7","author":"Gore","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.10.010_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/gut.45.4.489","article-title":"Endoscopic regression of Barrett\u2019s oesophagus during omeprazole treatment; a randomised double blind study","volume":"45","author":"Peters","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.010_bib37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/1055-9965.EPI-05-0528","article-title":"Effect of acid suppression on molecular predictors for esophageal cancer","volume":"15","author":"Lao-Sirieix","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.bpg.2011.10.010_bib38","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1080\/003655200453557","article-title":"Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus","volume":"35","author":"Peters","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.010_bib39","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1172\/JCI119018","article-title":"Dynamic effects of acid on Barrett\u2019s esophagus. An ex\u00a0vivo proliferation and differentiation model","volume":"98","author":"Fitzgerald","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bpg.2011.10.010_bib40","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett\u2019s esophagus","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.010_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","article-title":"Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett\u2019s oesophagus","volume":"180","author":"Hillman","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.bpg.2011.10.010_bib42","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa","volume":"118","author":"Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib43","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Yang","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2011.10.010_bib44","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bpg.2011.10.010_bib45","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.cgh.2007.09.010","article-title":"Use of acid-suppressing drugs and the risk of bacterial gastroenteritis","volume":"5","author":"Garcia Rodriguez","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"21","key":"10.1016\/j.bpg.2011.10.010_bib46","doi-asserted-by":"crossref","first-page":"13371","DOI":"10.1073\/pnas.222543099","article-title":"Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?","volume":"99","author":"Warner","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpg.2011.10.010_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/sonc.2002.34063","article-title":"A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer","volume":"29","author":"Howe","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bpg.2011.10.010_bib48","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2036.2006.03119.x","article-title":"Systematic review: cyclo-oxygenase-2 in human oesophageal adenocarcinogenesis","volume":"24","author":"Mehta","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.10.010_bib49","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/sj.bjp.0702897","article-title":"Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy","volume":"128","author":"Mitchell","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bpg.2011.10.010_bib50","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivity\u2019s for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in\u00a0vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.bpg.2011.10.010_bib51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/jnci\/94.6.422","article-title":"The effect of selective cyclooxygenase-2 inhibition in Barrett\u2019s esophagus epithelium: an in\u00a0vitro study","volume":"94","author":"Buttar","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpg.2011.10.010_bib52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/gast.2002.34244","article-title":"Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett\u2019s esophagus","volume":"123","author":"Kaur","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.010_bib53","first-page":"5767","article-title":"Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells","volume":"60","author":"Souza","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2011.10.010_bib54","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","article-title":"Celecoxib for the prevention of Sporadic colorectal adenomas","volume":"355","author":"Bertagnolli","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.bpg.2011.10.010_bib55","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","article-title":"Aspirin and reduced risk of esophageal carcinoma","volume":"76","author":"Ellen","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.bpg.2011.10.010_bib56","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/1097-0142(19860901)58:5<1029::AID-CNCR2820580508>3.0.CO;2-D","article-title":"Further studies on the therapeutic effect of indomethacin on esophageal tumors","volume":"58","author":"Rubio","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.bpg.2011.10.010_bib57","first-page":"1322","article-title":"Aspirin use and risk of fatal cancer","volume":"53","author":"Thun","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2011.10.010_bib58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and metaanalysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2011.10.010_bib59","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjc.6604880","article-title":"Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and ameta-analysis","volume":"100","author":"Abnet","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpg.2011.10.010_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.10.010_bib61","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jnci\/djh039","article-title":"Cost-effectiveness of aspirin chemoprevention for Barrett\u2019s esophagus","volume":"96","author":"Hur","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpg.2011.10.010_bib62","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1111\/j.1572-0241.2008.02117.x","article-title":"Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett\u2019s esophagus","volume":"103","author":"Hur","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.010_bib63","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1055-9965.EPI-04-0878","article-title":"The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland","volume":"14","author":"Macarthur","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.bpg.2011.10.010_bib64","first-page":"1305","article-title":"ProstaglandinHsynthase2variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia","volume":"11","author":"Lin","year":"2002","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.bpg.2011.10.010_bib65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00008469-200108000-00010","article-title":"Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers","volume":"10","author":"Terry","year":"2001","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.bpg.2011.10.010_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1054\/bjoc.2000.1121","article-title":"A case-control study of oesophageal adenocarcinoma in women: a preventable disease","volume":"83","author":"Cheng","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpg.2011.10.010_bib67","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/ijc.21678","article-title":"Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)","volume":"118","author":"Gonzalez","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpg.2011.10.010_bib68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1047>3.0.CO;2-I","article-title":"Fiber intake and the risk of oral, pharyngeal and esophageal cancer","volume":"91","author":"Soler","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpg.2011.10.010_bib69","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/1055-9965.EPI-05-0158","article-title":"Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus","volume":"14","author":"Kristal","year":"2005","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.bpg.2011.10.010_bib70","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0027-5107(01)00199-3","article-title":"Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett\u2019s esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants","volume":"480\u2013481","author":"Lee","year":"2001","journal-title":"Mutation Research\/Fundamental and Molecular Mechanisms of Mutagenesis"},{"key":"10.1016\/j.bpg.2011.10.010_bib71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/1078-0432.CCR-07-1152","article-title":"Chemoprevention of carcinogenic progression to esophageal adenocarcinoma by manganese superoxide dismutase supplementation","volume":"13","author":"Martin","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"9441","key":"10.1016\/j.bpg.2011.10.010_bib72","first-page":"1219","article-title":"Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis","volume":"364","author":"Bjelakovic","year":"2004","journal-title":"Original Research Article The Lancet"},{"key":"10.1016\/j.bpg.2011.10.010_bib73","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/1055-9965.EPI-07-0097","article-title":"Prospective cohort study of green tea consumption and colorectal cancer risk in women","volume":"16","author":"Yang","year":"2007","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.bpg.2011.10.010_bib74","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1053\/j.gastro.2006.08.010","article-title":"Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis","volume":"131","author":"Larsson","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2011.10.010_bib75","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1207\/s15327914nc5401_15","article-title":"Transitioning from Preclinical to clinical Chemopreventive assessments of Lyophilized black raspberries: Interim results show berries Modulate markers of oxidative stress in Barrett\u2019s esophagus patients","volume":"54","author":"Kresty","year":"2006","journal-title":"Nutr Cancer"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:49:43Z","timestamp":1741985383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691811000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":75,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1521691811000989"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2011.10.010","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}